دورية أكاديمية
أعرض في EDS

Predictors of Hospital-Acquired Clostridioides difficile Infection: A Systematic Review.

التفاصيل البيبلوغرافية
العنوان: Predictors of Hospital-Acquired Clostridioides difficile Infection: A Systematic Review.
المؤلفون: Puro N, Joseph R, Zengul FD, Cochran KJ, Camins BC, Ray M
المصدر: Journal for healthcare quality : official publication of the National Association for Healthcare Quality [J Healthc Qual] 2020 May/Jun; Vol. 42 (3), pp. 127-135.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Systematic Review
اللغة: English
بيانات الدورية: Publisher: National Association For Healthcare Quality Country of Publication: United States NLM ID: 9202994 Publication Model: Print Cited Medium: Internet ISSN: 1945-1474 (Electronic) Linking ISSN: 10622551 NLM ISO Abbreviation: J Healthc Qual
أسماء مطبوعة: Original Publication: Skokie Il : National Association For Healthcare Quality
مواضيع طبية MeSH: Predictive Value of Tests*, Clostridioides difficile/*isolation & purification , Clostridium Infections/*epidemiology , Clostridium Infections/*prevention & control , Cross Infection/*epidemiology , Cross Infection/*prevention & control , Risk Assessment/*methods, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; United States/epidemiology
مستخلص: Background: Clostridioides difficile infections (CDIs) have been identified as a major health concern due to the high morbidity, mortality, and cost of treatment. The aim of this study was to review the extant literature and identify the various patient-related, medication-related, and organizational risk factors associated with developing hospital-acquired CDIs in adult patients in the United States.
Methods: A systematic review of four (4) online databases, including Scopus, PubMed, CINAHL, and Cochrane Library, was conducted to identify empirical studies published from 2007 to 2017 pertaining to risk factors of developing hospital-acquired CDIs.
Findings: Thirty-eight studies (38) were included in the review. Various patient-level and medication-related risk factors were identified including advanced patient age, comorbidities, length of hospital stay, previous hospitalizations, use of probiotic medications and proton pump inhibitors. The review also identified organizational factors such as room size, academic affiliation, and geographic location to be significantly associated with hospital-acquired CDIs.
Conclusion: Validation of the factors associated with high risk of developing hospital-acquired CDIs identified in this review can aid in the development of risk prediction models to identify patients who are at a higher risk of developing CDIs and developing quality improvement interventions that might improve patient outcomes by minimizing risk of infection.
References: Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-834.
Yadav Y, Garey KW, Dao-Tran TK, Kaila V, Gbito KY, DuPont HL. Automated system to identify Clostridium difficile infection among hospitalised patients. J Hosp Infect. 2009;72(4):337-341.
Dubberke ER, Reske KA, Seiler S, Hink T, Kwon JH, Burnham CA. Risk factors for acquisition and loss of Clostridium difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;59(8):4533-4543.
Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis. 2016;16(1):447.
McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1-e48.
Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: Update of systematic review and meta-analysis. J Antimicrob Chemother. 2013;69(4):881-891.
Permpalung N, Upala S, Sanguankeo A, Sornprom S. Association between NSAIDs and Clostridium difficile-associated diarrhea: A systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2016;2016:7431838.
Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: A systematic review. J Antimicrob Chemother. 2003;51(6):1339-1350.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerging Infect Dis. 2010;16(4):604-609.
The PME. Observational studies: Getting clear about transparency. PLoS Med. 2014;11(8):e1001711.
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ. 1996;312(7023):71-72.
Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305-310.
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536.
Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt). 2007;8(6):557-566.
Tabak YP, Johannes RS, Sun X, Nunez CM, McDonald LC. Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score. Infect Control Hosp Epidemiol. 2015;36(6):695-701.
Tirath A, Tadros S, Coffin SL, et al. Clostridium difficile infection in dialysis patients. J Investig Med. 2017;65(2):353-357.
Zilberberg MD, Nathanson BH, Sadigov S, Higgins TL, Kollef MH, Shorr AF. Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest. 2009;136(3):752-758.
Lofgren ET, Cole SR, Weber DJ, Anderson DJ, Moehring RW. Hospital-acquired Clostridium difficile infections: Estimating all-cause mortality and length of stay. Epidemiology. 2014;25(4):570-575.
Abdelsattar ZM, Krapohl G, Alrahmani L, et al. Postoperative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015;36(1):40-46.
Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Intern Med. 2016;176(12):1801-1808.
Manian FA, Aradhyula S, Greisnauer S, et al. Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea. South Med J. 2007;100(8):782-786.
Tartof SY, Rieg GK, Wei R, Tseng HF, Jacobsen SJ, Yu KC. A comprehensive assessment across the healthcare continuum: Risk of hospital-associated Clostridium difficile infection due to outpatient and inpatient antibiotic exposure. Infect Control Hosp Epidemiol. 2015;36(12):1409-1416.
Lungulescu OA, Cao W, Gatskevich E, Tlhabano L, Stratidis JG. CSI: A severity index for Clostridium difficile infection at the time of admission. J Hosp Infect. 2011;79(2):151-154.
Baxter R, Ray GT, Fireman BH. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol. 2008;29(1):44-50.
Chung P, Currie B, Guo Y, et al. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection. Am J Infect Control. 2014;42(10):S264-S268.
Jou J, Ebrahim J, Shofer FS, et al. Environmental transmission of Clostridium difficile: Association between hospital room size and C. difficile infection. Infect Control Hosp Epidemiol. 2015;36(5):564-568.
Barletta JF, Sclar DA. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care. 2014;18(1):714.
Aquina CT, Probst CP, Becerra AZ, et al. High variability in nosocomial Clostridium difficile infection rates across hospitals after colorectal resection. Dis Colon Rectum. 2016;59(4):323-331.
Dasenbrock HH, Bartolozzi AR, Gormley WB, Frerichs KU, Aziz-Sultan MA, Du R. Clostridium difficile infection after subarachnoid hemorrhage: A nationwide analysis. Neurosurgery. 2016;78(3):412-420.
Kumarappa VS, Patel H, Shah A, Baddoura W, DeBari VA. Temporal changes in serum albumin and total protein in patients with hospital-acquired Clostridium difficile infection. Ann Clin Lab Sci. 2014;44(1):32-37.
Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Proton pump inhibitors do not increase risk for Clostridium difficile infection in the intensive care unit. Am J Gastroenterol. 2016;111(11):1641-1648.
Cruz-Betancourt A, Cooper CD, Sposato K, et al. Effects of a predictive preventive model for prevention of Clostridium difficile infection in patients in intensive care units. Am J Infect Control. 2016;44(4):421-424.
Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008;103(9):2308-2313.
Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton). 2010;15(4):471-475.
Simmering JE, Polgreen LA, Campbell DR, Cavanaugh JE, Polgreen PM. Hospital transfer network structure as a risk factor for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015;36(9):1031-1037.
Pakyz AL, Jawahar R, Wang Q, Harpe SE. Medication risk factors associated with healthcare-associated Clostridium difficile infection: A multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother. 2014;69(4):1127-1131.
Akhtar AJ, Shaheen M. Increasing incidence of clostridium difficile-associated diarrhea in african-American and hispanic patients: Association with the use of proton pump inhibitor therapy. J Natl Med Assoc. 2007;99(5):500-504.
Campbell KA, Phillips MS, Stachel A, Bosco JA III, Mehta SA. Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital. J Hosp Infect. 2013;83(2):146-149.
Flagg A, Koch CG, Schiltz N, et al. Analysis of Clostridium difficile infections after cardiac surgery: Epidemiologic and economic implications from national data. J Thorac Cardiovasc Surg. 2014;148(5):2404-2409.
Ricciardi R, Harriman K, Baxter NN, Hartman LK, Town RJ, Virnig BA. Predictors of Clostridium difficile colitis infections in hospitals. Epidemiol Infect. 2008;136(7):913-921.
Yoshikawa TT, Norman DC. Geriatric infectious diseases: Current concepts on diagnosis and management. J Am Geriatr Soc. 2017;65(3):631-641.
Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500-6515.
Kuster SP, Ruef C, Bollinger AK, et al. Correlation between case mix index and antibiotic use in hospitals. J Antimicrob Chemother. 2008;62(4):837-842.
تواريخ الأحداث: Date Created: 20191211 Date Completed: 20210112 Latest Revision: 20210124
رمز التحديث: 20221213
DOI: 10.1097/JHQ.0000000000000236
PMID: 31821178
قاعدة البيانات: MEDLINE
الوصف
تدمد:1945-1474
DOI:10.1097/JHQ.0000000000000236